2020-11-01
Czech Liaison Office for Research, Development and Innovation (CZELO) distinguished our project as the example of good practice realized with the support from Horizon 2020 by the company from Visegrad countries (see page 58 of the brochure)
Link
https://cordis.europa.eu/project/id/830559
Download PDF
https://poltreg.com/wp-content/uploads/2020/12/CZELO-V4-Brochure-H2020-Good-Practice.pdf
2025-06-13
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy
2025-04-23
PolTREG accelerates the development of next-generation antigen-specific Tregtherapy for Type 1 Diabetes
2025-03-27
PolTREG partners with Noble Capital Markets Inc. to prepare for potential fundraising in the U.S.
2025-03-25
Webinar: PolTREG’s Strategic Collaboration with Antion Biosciences and Growth Prospects for 2025
